Quentin Lecocq
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
Journal: Frontiers in immunology
Published: February 20, 2024
Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 24, 2022
Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 10, 2022
Emerging applications of nanobodies in cancer therapy.
Journal: International review of cell and molecular biology
Published: July 01, 2022
TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy.
Journal: Frontiers in immunology
Published: November 09, 2021
Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma.
Journal: Frontiers in immunology
Published: October 21, 2021
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model.
Journal: Molecular cancer therapeutics
Published: October 03, 2021
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer.
Journal: EJNMMI research
Published: August 11, 2021
Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide-Cysteine Chemistry.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 29, 2021
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade.
Journal: Molecular therapy. Methods & clinical development
Published: November 24, 2020
The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm.
Journal: International journal of molecular sciences
Published: November 09, 2020
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development.
Journal: Cancers
Published: October 22, 2020
Last Updated: 09/26/2026